Presumed safe no more: lessons from the Wingspan saga on regulation of devices
2014; Volume: 348; Issue: jan22 2 Linguagem: Inglês
10.1136/bmj.g93
ISSN1756-1833
AutoresAri J. Gartenberg, Ariel Peleg, S. S. Dhruva, Rita F. Redberg,
Tópico(s)Intracranial Aneurysms: Treatment and Complications
ResumoDespite a randomized controlled trial showing clear safety concerns with the Wingspan intracranial stent system, the device remains on the market. Ari J Gartenberg and colleagues argue that the exemption system used to obtain its market approval in the US is not adequate for high risk devices
Referência(s)